Application no. and date | 11192240.7 (espacenet) (Federated) (European Patent Register), 20061205 | Patent/reg. no. and date | DK/EP 2481753, 20180418 | Publication date | 20120801 | Priority no. and date | US 749953 P, 20051213, US 801948 P, 20060519 | EP pub. no. and date |
EP 2481753 20120801 | Effective date | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | P81203112DK01E | Inventor | NG, Kingman, 10745 Putnam Place
Carmel, Indiana 46032, US, Allan, Barrett, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Chow, Chi-kin, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Huang, Lihua, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Liu, Ling, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Lu, Jirong, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Tetreault, Jonathan Wendell, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US, Werner, Andrew Gordon, Eli Lilly and Company Lilly Corporate Center
Indianapolis, IN 46285, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/395 (2006.01) , C07K 16/24 (2006.01) | Title | Anti-IL-17-antistoffer | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|